A detailed history of D. E. Shaw & Co., Inc. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 130,466 shares of VERA stock, worth $5.56 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
130,466
Holding current value
$5.56 Million
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$34.09 - $46.71 $8.19 Million - $11.2 Million
-240,219 Reduced 64.8%
130,466 $5.77 Million
Q2 2024

Aug 14, 2024

SELL
$33.72 - $48.82 $7.77 Million - $11.2 Million
-230,351 Reduced 38.33%
370,685 $13.4 Million
Q1 2024

May 15, 2024

BUY
$14.91 - $49.14 $5.83 Million - $19.2 Million
390,997 Added 186.15%
601,036 $25.9 Million
Q4 2023

Feb 14, 2024

BUY
$9.29 - $16.0 $481,714 - $829,648
51,853 Added 32.78%
210,039 $3.23 Million
Q3 2023

Nov 14, 2023

BUY
$13.71 - $19.64 $2.17 Million - $3.11 Million
158,186 New
158,186 $2.17 Million

Others Institutions Holding VERA

About Vera Therapeutics, Inc.


  • Ticker VERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,042,300
  • Market Cap $1.15B
  • Description
  • Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...
More about VERA
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.